Delivering mitochondrial health
In early January 2024, Abliva's CEO, Ellen Donnelly, will attend the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, USA. The conference is a healthcare investment symposium that connects […]
In mid-March, Abliva will attend the 8th edition of Mitochondrial Medicine - Therapeutic Development in Hinxton, UK. This annual scientific meeting is focused on mitochondrial disorders and the search for […]
In mid-April, Abliva will participate at Kempen Life Sciences Conference in Amsterdam, The Netherlands. For more information, please click the link below.
In mid-May, Abliva will travel to the Bio€quity Europe meeting in San Sebastán, Spain. "For more than 20 years, Bio€quity Europe has been where CEOs and investors gather to network, […]
Join Abliva for a virtual KOL event featuring Amel Karaa, MD (Massachusetts General Hospital), who will discuss the unmet medical need and current treatment landscape for patients with primary mitochondrial […]
In early June, Abliva's CEO, Ellen Donnelly, travels to San Diego to attend BIO International 2024. Follow the link below for more information.
In late June, Abliva will attend the US patient organization UMDF’s Mitochondrial Medicine Conference in Cleveland, Ohio. "Each year, UMDF’s Mitochondrial Medicine Conference brings together the best minds in mitochondrial […]
In September, Abliva will attend the Nordic Life Science Days (NLS days) in Malmö, Sweden. Ablia's CEO, Ellen Donnelly, will be presenting the company at 11:00 a.m. CET on September […]
In late October, Abliva will attend the 14th Mitochondrial Disease Conference, this year in Padua (IT), organized by the Italian patient organization Mitocon. Abliva's CMO, Magnus Hansson will attend the […]
In early November, Abliva's CEO, Ellen Donnelly, will attend the BIO-Europe meeting in Stockholm, Sweden. On Monday, November 4, Ellen will be presenting the company at 4:30 p.m. CET. Follow […]
Abliva will attend the CNS Summit 2024, taking place November 10-13 at Encore Boston Harbor. The company's CEO, Ellen Donnelly, has organized and will join the spotlight panel discussion: Medicines […]
In mid-November, Abliva will attend LSX's Investival Showcase in London, UK. Abliva's CEO, Ellen Donnelly, will be presenting the company at 11:30 a.m. GMT. The Investival Showcase is a Biotech, […]
